期刊文献+

咖啡酸衍生物的合成及其抑制HIV整合酶活性 被引量:2

Synthesis and HIV integrase inhibitory activity of caffeic acid derivatives
下载PDF
导出
摘要 目的合成新型咖啡酸衍生物并测定其抑制HIV 1整合酶活性。方法化学合成一系列N 取代咖啡酰萘磺胺类化合物,采用3 2 P标记法体外测定化合物抑制HIV 1整合酶活性。结果合成了2 0个咖啡酸衍生物,其结构经红外光谱、核磁共振氢谱及质谱确定。其中化合物Ⅰ2 、Ⅰ3 、Ⅰ4抑制HIV 1整合酶活性高于L 巨菊酸(IC50 =11 8μg·mL-1) ,3个化合物的IC50 分别为(8 .6±4 . 8)、(4. 5±3 .4 )、(7 .9±4 . 9) μg·mL-1。结论N 取代咖啡酰萘磺胺类化合物对HIV 1整合酶有较高抑制活性,值得深入研究。 Aim To synthesize a series of new caffeic acid derivatives and test their HIV-1 integrase inhibitory activities.Methods A series of N-substituted caffeoyl-naphthalenesulfonaminde derivatives were synthesized by six-step reactions.HIV-1 integrase inhibitory assay of these compounds was carried out by ()^(32)P-marked experiments in vitro.Resluts Twenty caffeic acid derivatives were synthesized and confirmed by IR,()~1H-NMR and MS.Among these compounds,the HIV-1 integrase inhibitory activities of compounds Ⅰ_2,Ⅰ_3 and Ⅰ_4 were more potent than that of L-chicoric acid(IC_(50)=11.8 μg ·mL^(-1)).Conclusion N-substituted caffeoyl-naphthalenesulfonaminde derivatives show remarkable HIV-1 integrase inhibitory activities,and further research is underway.
机构地区 山东大学药学院
出处 《中国药物化学杂志》 CAS CSCD 2005年第2期70-75,共6页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金资助项目 (2 0 4 72 0 4 5 ) 山东省自然科学基金资助项目 (Y2 0 0 3C19)
关键词 药物化学 构效关系 化学合成 HIV-1整合酶抑制剂 medicinal chemistry SAR chemical synthesis HIV-1 integrase inhibitor
  • 相关文献

参考文献8

  • 1徐玉文,赵桂森,刘永久.人免疫缺陷病毒整合酶抑制剂的研究现状[J].药学进展,2002,26(3):138-142. 被引量:9
  • 2徐玉文,赵桂森.抗艾滋病药物研究进展[J].中国药物化学杂志,2002,12(2):119-124. 被引量:13
  • 3Robinson WE Jr, Reinecke MG, Abdel-Malek S, et al.Inhibitors of HIV-i replication that inhibit HIV integrase[J]. Proc Natl Acad Sci USA, 1996, 93 (13):6326 - 6331.
  • 4Robinson WE Jr, Cordeiro M, Abdel-Malek S, et al. Dicaffeoylquinic acid inhibitors of HIV integrase: inhibition of the core catalytic domain of HIV integrase[J].Mol Pharmacol, 1996, 50(4) :846 - 855.
  • 5Hwang DJ, Kim SN, Choi JH, et al. Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors [J]. Bioorg Med Chem, 2001, 9 (6):1429 - 1437.
  • 6Sotriffer CA, Ni H, McCammon JA. Active site binding modes of HIV-1 integrase inhibitors[J]. J Med Chem,2000, 43(22):4109 - 4117.
  • 7Stein PD, Hunt JT. Sulfonamide endothelin antagonists[P]. US:5378715, 1995 - 01 - 03.
  • 8Oh JW, Shin CG. Purification and characterization of the human immunodeficiency virus type 1 integrase expressed in Escherichia coli[J]. Mol Cells, 1996, 6(1):96- 100.

二级参考文献27

  • 1何军林.抗病毒药物的研究进展[J].国外医学(药学分册),1996,23(6):321-327. 被引量:3
  • 2[1]Pommier Y, Marchand C, Neamati N. Retroviral integrase inhibit ors year 2000: update and perspectives[J]. Antiviral Res,2000,47:139-148.
  • 3[2]Esposito D, Craigie R. HIV integrase structure and function[A]. In : Skalka A M (Ed.). Advances in Virus Research[M], San Diego: Acad emic Press, 1999,Vol.52 pp:319-333.
  • 4[3]Craigie R. HIV integrase, a brief overview from chemistry to therapeu tics[J]. J Biol Chem, 2001,276(26):23213-23216.
  • 5[4]Drake R, Neamati N, Hong H, et al. Identification of a nucleotide b inding site in HIV-1 integrase[J]. Proc Natl Acad Sci USA, 1993,95:4170- 4175.
  • 6[5]Goldgur Y, Craigie R, Cohen C H, et al. Structure of the HIV-integra se catalytic domain complexed with an inhibitor:a platform for antiviral drug de sign[J]. Proc Natl Acad Sci USA, 1999,96:13040-13043.
  • 7[6]Jing N, Marchad C, Liu J, et al. Mechanism of inhibition of HIV-1 in teg rase by G-tetra forming oligonucleotides[J]. J Biol Chem, 2000,275:21460 -21467.
  • 8[7]Caumont A, Jamieson G, Soultrait V R, et al. High affinityinteraction of HIV-1 integrase with specific and non-specific single-stranded short oli gonucleotides[J]. FEBS Lett, 1999,455:154-158.
  • 9[8]Daria J, Hazuda P F, Witmer M, et al. Inhibitors of strand transfer t hat prevent integration and inhibit HIV-1 replication in cells[J]. Science, 2000,287:646-650.
  • 10[9]Goldgur Y, Craigie R, Cohen G H, et al. Structure of the HIV-integr ase catalytic domain complexed with an inhibitorf a pIatform for antiviral drug design[J]. Proc Natl Acad Sci USA,1999,96:13040-13043.

共引文献18

同被引文献57

  • 1李继航,陈明清,胡娜,倪忠斌,金帅甬,娄宇.咖啡酸衍生物基聚酯及其共聚物的研究进展[J].高分子通报,2010(10):60-65. 被引量:5
  • 2叶连宝,陈晓东,赵华,颜小明.阿魏酸锗对小鼠子宫颈癌14号的抑制作用[J].安徽医药,2005,9(8):570-571. 被引量:9
  • 3吴卫华,康桢,欧阳冬生,周宏灏.绿原酸的药理学研究进展[J].天然产物研究与开发,2006,18(4):691-694. 被引量:211
  • 4钟益宁.姜黄素合成方法改进的研究[J].江西师范大学学报(自然科学版),2007,31(3):282-284. 被引量:3
  • 5罗铭清.中草药有效成分理化与药理特性[M].长沙:湖南科学技术出版社,1982.225-226.
  • 6Tanaka T, Kojima T, Kawamori T, et al. Inhibition of 4-nitroquinoline-l-oxide- induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids [J]. Carcinogenesis, 1993, 14(7): 1321-1325.
  • 7I ay S, Gueux E, Rayssiguier Y, et al. Caffeic acid inhibits oxidative stress and reduces hypercholesterolemia induces by iron overload in rats[J]. Int J Vitam Nu " Res, 2005, 75(2): 119-15.
  • 8Grunberger D, Bane-ee R, Eisinger K, et al. Preferential cytotoxieity on tumor cells by eaffeie acid phenethyl ester isolated from propo]is [J]. Experientia, 1988, 44 (3): 230- 232.
  • 9Chela Y, Shiao M, Hsu M, ctal. Effect of caffeic acid phenethyl ester, all antioxidant from propo]is, on inducing apoptosis in human leukemic HL-60 cens[J]. Agrie Food Chem, 2001, 49 (11): 5615-5619.
  • 10Sudina G F, Mirzoeva O K, Pushkareva M A, eta]. Caffeic acidphenethyl ester as alipoxygenase inhibitor with antioxidant properties [J]. FEBS Lett, 1993, 329(1-2): 21-24.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部